CL2015001695A1 - Una composicion de dos componentes para entregar zinc a un cuerpo comprendiendo (i) un primer componente de un complejo de halogenuro de zinc y (aminoacido o trialquilglicina) y (ii) un segundo componente de cisteina, en donde el primer y segundo componente se mantienen separados uno del otro hasta que se dispensan y se combinan para aplicarse al cuerpo, util para el cuidado oral y personal. - Google Patents

Una composicion de dos componentes para entregar zinc a un cuerpo comprendiendo (i) un primer componente de un complejo de halogenuro de zinc y (aminoacido o trialquilglicina) y (ii) un segundo componente de cisteina, en donde el primer y segundo componente se mantienen separados uno del otro hasta que se dispensan y se combinan para aplicarse al cuerpo, util para el cuidado oral y personal.

Info

Publication number
CL2015001695A1
CL2015001695A1 CL2015001695A CL2015001695A CL2015001695A1 CL 2015001695 A1 CL2015001695 A1 CL 2015001695A1 CL 2015001695 A CL2015001695 A CL 2015001695A CL 2015001695 A CL2015001695 A CL 2015001695A CL 2015001695 A1 CL2015001695 A1 CL 2015001695A1
Authority
CL
Chile
Prior art keywords
component
zinc
trialkylglycine
dispensed
oral
Prior art date
Application number
CL2015001695A
Other languages
English (en)
Inventor
Long Pan
Shaotang Yuan
Zhiqiang Liu
Joseph Convery
Harsh M Trivedi
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/070525 external-priority patent/WO2014098826A1/en
Priority claimed from PCT/US2012/070498 external-priority patent/WO2014098818A1/en
Priority claimed from PCT/US2012/070521 external-priority patent/WO2014098825A1/en
Priority claimed from PCT/US2012/070537 external-priority patent/WO2014098829A1/en
Priority claimed from PCT/US2012/070506 external-priority patent/WO2014098822A1/en
Priority claimed from PCT/US2012/070505 external-priority patent/WO2014098821A1/en
Priority claimed from PCT/US2012/070501 external-priority patent/WO2014098819A1/en
Priority claimed from PCT/US2012/070534 external-priority patent/WO2014098828A1/en
Priority claimed from PCT/US2012/070492 external-priority patent/WO2014098814A1/en
Priority claimed from PCT/US2012/070513 external-priority patent/WO2014098824A1/en
Priority claimed from PCT/US2012/070489 external-priority patent/WO2014098813A1/en
Priority claimed from PCT/US2013/046268 external-priority patent/WO2014204439A1/en
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of CL2015001695A1 publication Critical patent/CL2015001695A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/882—Mixing prior to application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
CL2015001695A 2012-12-19 2015-06-17 Una composicion de dos componentes para entregar zinc a un cuerpo comprendiendo (i) un primer componente de un complejo de halogenuro de zinc y (aminoacido o trialquilglicina) y (ii) un segundo componente de cisteina, en donde el primer y segundo componente se mantienen separados uno del otro hasta que se dispensan y se combinan para aplicarse al cuerpo, util para el cuidado oral y personal. CL2015001695A1 (es)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
PCT/US2012/070521 WO2014098825A1 (en) 2012-12-19 2012-12-19 Oral care products comprising a tetrabasic zinc - amino acid - halide complex
PCT/US2012/070537 WO2014098829A1 (en) 2012-12-19 2012-12-19 Oral care products comprising zinc oxide and trimethylglycine
PCT/US2012/070506 WO2014098822A1 (en) 2012-12-19 2012-12-19 Zinc amino acid halide mouthwashes
PCT/US2012/070505 WO2014098821A1 (en) 2012-12-19 2012-12-19 Method for indicating time for washing or indicating delivery of antibacterial agent
PCT/US2012/070525 WO2014098826A1 (en) 2012-12-19 2012-12-19 Oral care compositions comprising zinc amino acid halides
PCT/US2012/070489 WO2014098813A1 (en) 2012-12-19 2012-12-19 Zinc amino acid/trimethylglycine halide
PCT/US2012/070498 WO2014098818A1 (en) 2012-12-19 2012-12-19 Zinc-lysine complex
PCT/US2012/070513 WO2014098824A1 (en) 2012-12-19 2012-12-19 Oral gel comprising zinc - amino acid complex
PCT/US2012/070492 WO2014098814A1 (en) 2012-12-19 2012-12-19 Composition with zinc amino acid/trimethylglycine halide precursors
PCT/US2012/070534 WO2014098828A1 (en) 2012-12-19 2012-12-19 Teeth whitening methods, visually perceptible signals and compositions therefor|comprising zinc amino acid halides
PCT/US2012/070501 WO2014098819A1 (en) 2012-12-19 2012-12-19 Antiperspirant products with protein and antiperspirant salts
PCT/US2013/046268 WO2014204439A1 (en) 2013-06-18 2013-06-18 Zinc amino acid halide complex with cysteine
PCT/US2013/050845 WO2014099039A2 (en) 2012-12-19 2013-07-17 Method for indicating time for washing or indicating delivery of antibacterial agent

Publications (1)

Publication Number Publication Date
CL2015001695A1 true CL2015001695A1 (es) 2015-08-28

Family

ID=50979373

Family Applications (4)

Application Number Title Priority Date Filing Date
CL2015001694A CL2015001694A1 (es) 2012-12-19 2015-06-17 Composicion que comprende un complejo de haluro de zinc tetrabasico-aminoacido o trialquil glicina y cisteina en forma libre o de sal aceptable oralmente o cosmetico; y su uso para eliminar bacterias, reducir la transpiracion y/o el olor corporal, tratar o reducir el acne, limpiar los dientes e inhibir las caries, entre otros.
CL2015001695A CL2015001695A1 (es) 2012-12-19 2015-06-17 Una composicion de dos componentes para entregar zinc a un cuerpo comprendiendo (i) un primer componente de un complejo de halogenuro de zinc y (aminoacido o trialquilglicina) y (ii) un segundo componente de cisteina, en donde el primer y segundo componente se mantienen separados uno del otro hasta que se dispensan y se combinan para aplicarse al cuerpo, util para el cuidado oral y personal.
CL2015001760A CL2015001760A1 (es) 2012-12-19 2015-06-19 Composicion de componente doble para suministrar zinc a un cuerpo que comprende un complejo de halogenuro de zinc tetrabásico-aminoácido y cisteína; y metodo de eliminacion de bacterias, reduccion de la transpiracion y/o reduccion del olor corporal, por medio de la aplicacion a la piel de la composicion.
CL2015001792A CL2015001792A1 (es) 2012-12-19 2015-06-19 Una composicion que comprende (i) un complejo de haluro de (aminoacido o trialquil glicina) y zinc y (ii) cisteina, util para la eliminacion de las bacterias, la reduccion de la transpiracion y/o la reduccion del olor corporal, o para el cuidado oral, entre otras.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2015001694A CL2015001694A1 (es) 2012-12-19 2015-06-17 Composicion que comprende un complejo de haluro de zinc tetrabasico-aminoacido o trialquil glicina y cisteina en forma libre o de sal aceptable oralmente o cosmetico; y su uso para eliminar bacterias, reducir la transpiracion y/o el olor corporal, tratar o reducir el acne, limpiar los dientes e inhibir las caries, entre otros.

Family Applications After (2)

Application Number Title Priority Date Filing Date
CL2015001760A CL2015001760A1 (es) 2012-12-19 2015-06-19 Composicion de componente doble para suministrar zinc a un cuerpo que comprende un complejo de halogenuro de zinc tetrabásico-aminoácido y cisteína; y metodo de eliminacion de bacterias, reduccion de la transpiracion y/o reduccion del olor corporal, por medio de la aplicacion a la piel de la composicion.
CL2015001792A CL2015001792A1 (es) 2012-12-19 2015-06-19 Una composicion que comprende (i) un complejo de haluro de (aminoacido o trialquil glicina) y zinc y (ii) cisteina, util para la eliminacion de las bacterias, la reduccion de la transpiracion y/o la reduccion del olor corporal, o para el cuidado oral, entre otras.

Country Status (18)

Country Link
EP (5) EP2934451B1 (es)
JP (2) JP6348509B2 (es)
KR (4) KR102030761B1 (es)
CN (6) CN104884033B (es)
AR (1) AR094077A1 (es)
AU (5) AU2013364205B2 (es)
BR (5) BR112015014760A2 (es)
CA (5) CA2892359C (es)
CL (4) CL2015001694A1 (es)
HK (3) HK1216016A1 (es)
IL (2) IL239003A0 (es)
IN (2) IN2015DN04226A (es)
MX (5) MX362447B (es)
MY (1) MY170532A (es)
PH (5) PH12015501342A1 (es)
RU (5) RU2618472C2 (es)
TW (4) TWI510251B (es)
WO (5) WO2014099164A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104853721B (zh) 2012-12-19 2017-10-27 高露洁-棕榄公司 锌精氨酸/赖氨酸卤化物
CN104853812B (zh) 2012-12-19 2018-07-10 高露洁-棕榄公司 具有蛋白质和止汗盐的止汗剂产品
BR112015014758B1 (pt) 2012-12-19 2019-04-09 Colgate-Palmolive Company Produtos de cuidado oral compreendendo óxido de zinco e trimetilglicina
CN104884033B (zh) * 2012-12-19 2018-04-20 高露洁-棕榄公司 锌氨基酸络合物与半胱氨酸
WO2014098824A1 (en) 2012-12-19 2014-06-26 Colgate-Palmolive Company Oral gel comprising zinc - amino acid complex
US9498421B2 (en) 2012-12-19 2016-11-22 Colgate-Palmolive Company Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine
US9750670B2 (en) 2012-12-19 2017-09-05 Colgate-Palmolive Company Zinc amino acid complex with cysteine
US9675823B2 (en) 2012-12-19 2017-06-13 Colgate-Palmolive Company Two component compositions containing zinc amino acid halide complexes and cysteine
US10188112B2 (en) 2012-12-19 2019-01-29 Colgate-Palmolive Company Personal cleansing compositions containing zinc amino acid/trimethylglycine halide
CN104853728B (zh) 2012-12-19 2018-07-24 高露洁-棕榄公司 牙齿增白方法、视觉可感知的信号及为此包含锌氨基酸卤化物的组合物
US9504858B2 (en) 2012-12-19 2016-11-29 Colgate-Palmolive Company Zinc amino acid halide complex with cysteine
MX355285B (es) 2012-12-19 2018-04-13 Colgate Palmolive Co Composicion con precursores de haluros de zinc aminoacidos/trimetilglicina.
BR112015014445A2 (pt) 2012-12-19 2017-07-11 Colgate Palmolive Co complexo de zinco-lisina
US10105303B2 (en) 2012-12-19 2018-10-23 Colgate-Palmolive Company Oral care composition comprising zinc amino acid halides
BR112015014453B1 (pt) 2012-12-19 2019-06-11 Colgate-Palmolive Company Composição para higiene oral, complexo iônico, usos de um haleto de zinco tetrabásico em conjunto com trimetilglicina na forma de sal de adição de ácido e complexo
RU2625763C2 (ru) 2012-12-19 2017-07-18 Колгейт-Палмолив Компани Продукты для ухода за полостью рта, содержащие комплекс четырехосновный цинк-аминокислота-галогенид
US9980890B2 (en) 2012-12-19 2018-05-29 Colgate-Palmolive Company Zinc amino acid halide mouthwashes
BR112017022812B1 (pt) 2015-05-01 2020-10-20 Colgate-Palmolive Company Composições de dentifrício com baixo teor de água
KR101889677B1 (ko) 2015-06-12 2018-08-17 제이에프이미네라르 가부시키가이샤 피부 창상 또는 피부 거침 치료제
DE102015214145A1 (de) * 2015-07-27 2017-02-02 Beiersdorf Ag Schweiß verringernde kosmetische Zubereitung
DE102015214137A1 (de) * 2015-07-27 2017-02-02 Beiersdorf Ag Schweiß verringernde kosmetische Zubereitung
DE102015214144A1 (de) * 2015-07-27 2017-02-02 Beiersdorf Ag Schweiß verringernde kosmetische Zubereitung
MX368894B (es) * 2015-12-22 2019-10-21 Colgate Palmolive Co Composiciones para el cuidado bucal que comprenden haluros de aminoacidos y zinc.
CN108430589B (zh) * 2015-12-31 2021-08-24 高露洁-棕榄公司 个人护理组合物
CN105908324A (zh) * 2016-06-29 2016-08-31 江苏华信亚麻纺织有限公司 一种棉麻交织双层布
JP7004378B2 (ja) * 2017-03-24 2022-02-10 Ｎｅｃソリューションイノベータ株式会社 アプタマーセットの選択方法
AU2018388437B2 (en) * 2017-12-19 2021-10-07 Colgate-Palmolive Company Personal care compositions
WO2023152199A1 (en) * 2022-02-09 2023-08-17 Unilever Ip Holdings B.V. Use of oral care composition comprising zinc

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE735096C (de) 1940-12-09 1943-05-06 Ig Farbenindustrie Ag Verfahren zur Herstellung von Sulfonsaeuren
US2503280A (en) 1947-10-24 1950-04-11 Du Pont Azo catalysts in preparation of sulfonic acids
US2507088A (en) 1948-01-08 1950-05-09 Du Pont Sulfoxidation process
FR1247957A (fr) 1958-09-28 1960-12-09 Ajinomoto Kk Procédé de séparation continue d'aminoacides racémiques
US3320174A (en) 1964-04-20 1967-05-16 Colgate Palmolive Co Detergent composition
US3372188A (en) 1965-03-12 1968-03-05 Union Oil Co Sulfoxidation process in the presence of sulfur trioxide
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US3678154A (en) 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3535421A (en) 1968-07-11 1970-10-20 Procter & Gamble Oral compositions for calculus retardation
US3741911A (en) 1970-12-21 1973-06-26 Hart Chemical Ltd Phosphate-free detergent composition
US3959458A (en) 1973-02-09 1976-05-25 The Procter & Gamble Company Oral compositions for calculus retardation
US3937807A (en) 1973-03-06 1976-02-10 The Procter & Gamble Company Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies
US3862307A (en) 1973-04-09 1975-01-21 Procter & Gamble Dentifrices containing a cationic therapeutic agent and improved silica abrasive
US3941818A (en) * 1973-08-20 1976-03-02 Zinpro Corporation 1:1 Zinc methionine complexes
US4051234A (en) 1975-06-06 1977-09-27 The Procter & Gamble Company Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies
US4340583A (en) 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
CA1139229A (en) * 1979-06-20 1983-01-11 Thomas W. Ritchey Zinc salt with glycine in oral composition
US4316824A (en) 1980-06-26 1982-02-23 The Procter & Gamble Company Liquid detergent composition containing alkyl sulfate and alkyl ethoxylated sulfate
JPS57156329A (en) * 1981-03-19 1982-09-27 Shiseido Co Ltd Solubilization of zinc oxide
JPS57158724A (en) * 1981-03-26 1982-09-30 Shiseido Co Ltd Antimicrobial composition
US4565693A (en) * 1981-11-09 1986-01-21 Colgate-Palmolive Company Deodorant composition
US4487757A (en) 1981-12-28 1984-12-11 Colgate-Palmolive Company Dispensing container of toothpaste which effervesces during toothbrushing
IL64700A0 (en) * 1982-01-01 1982-03-31 Binderman Itzhak Dental care compositions
US4885155A (en) 1982-06-22 1989-12-05 The Procter & Gamble Company Anticalculus compositions using pyrophosphate salt
DE3238118A1 (de) * 1982-10-14 1984-04-19 Verla-Pharm, Arzneimittelfabrik Apotheker H.J. v. Ehrlich GmbH & Co KG, 8132 Tutzing Verfahren zur herstellung von komplexverbindungen aus aminodicarbonsaeuren, zweiwertigen metallionen und halogenidionen
US4687663B1 (en) 1983-03-01 1997-10-07 Chesebrough Ponds Usa Co Dental preparation article and method for storage and delivery thereof
US4642445A (en) * 1985-06-28 1987-02-10 Westinghouse Electric Corp. Shielding apparatus for metal processing operations
US5188821A (en) 1987-01-30 1993-02-23 Colgate-Palmolive Company Antibacterial antiplaque oral composition mouthwash or liquid dentifrice
US5192531A (en) 1988-12-29 1993-03-09 Colgate-Palmolive Company Antibacterial antiplaque oral composition
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
US4866161A (en) 1987-08-24 1989-09-12 University Of South Alabama Inhibition of tartar deposition by polyanionic/hydrophobic peptides and derivatives thereof which have a clustered block copolymer structure
US5004597A (en) 1987-09-14 1991-04-02 The Procter & Gamble Company Oral compositions comprising stannous flouride and stannous gluconate
US4842847A (en) 1987-12-21 1989-06-27 The B. F. Goodrich Company Dental calculus inhibiting compositions
US5061815A (en) * 1988-07-06 1991-10-29 Zinpro Corporation Metal lysine complexes and method for producing metal lysine complexes
GB2243775A (en) * 1990-05-09 1991-11-13 Unilever Plc Oral compositions
JPH0578243A (ja) * 1990-12-11 1993-03-30 Shiseido Co Ltd 鎮痒剤及び鎮痒組成物
GB9107833D0 (en) * 1991-04-12 1991-05-29 Unilever Plc Treatment of periodontitis
US5643559A (en) * 1991-10-30 1997-07-01 Colgate-Palmolive Company Deodorant compositions comprising inhibitors of odor-producing axillary bacterial exoenzymes
US5714447A (en) * 1996-01-24 1998-02-03 Church & Dwight Co., Inc. Deodorant soap or detergent composition containing a zinc compound and a polyamine
CN1241934A (zh) * 1996-10-31 2000-01-19 尤尼利弗公司 含有金属－氨基酸络合物的头发处理组合物
DK176196B1 (da) 1997-10-07 2007-01-08 Ejvind Jersie Pedersen Mundhygejnepræparat til behandling af halitosis samt anvendelse af et chelat omfattende en metaliondel og en aminosyredel som en komponent i præparatet
BR9910981A (pt) * 1998-06-09 2004-08-03 William J Embro Composição e uso da mesma para o tratamento de irritações e infeções epidérmicas
US6558710B1 (en) * 1999-06-14 2003-05-06 Helen Rebecca Godfrey Topical zinc compositions and methods of use
US7164035B2 (en) * 2000-01-07 2007-01-16 Newsome David A Zinc-monocysteine complex and method of using zinc-cysteine complexes
US20030003059A1 (en) 2001-04-03 2003-01-02 Frederic Dana Dentifrice compositions
US6660699B2 (en) * 2001-09-28 2003-12-09 Unilever Home & Personal Care Usa Toilet bar having a latent acidifier
RU2226109C1 (ru) * 2002-07-24 2004-03-27 Закрытое акционерное общество "ЭЛИТ ХОЛДИНГ" Дезинфицирующее средство (варианты)
US20040033916A1 (en) * 2002-06-28 2004-02-19 Kuzmin Vladimir Semenovich Disinfecting composition
JP2004175790A (ja) * 2002-11-12 2004-06-24 Arita Junichi α−グルコシダーゼ阻害作用を有する亜鉛含有物
US20040198998A1 (en) * 2003-04-04 2004-10-07 Marian Holerca Glycine-free antiperspirant salts with betaine for enhanced cosmetic products
JP4377263B2 (ja) * 2004-03-03 2009-12-02 日光ケミカルズ株式会社 化粧料及び皮膚外用剤
JP4444073B2 (ja) * 2004-11-04 2010-03-31 株式会社ナリス化粧品 化粧料
CN101128181B (zh) * 2005-03-10 2011-11-23 株式会社资生堂 油系皮肤外用剂
US7700079B2 (en) * 2005-09-26 2010-04-20 Jamie Collins Doss Therapeutic soap product with UV protection
EP1954239A2 (en) * 2005-11-29 2008-08-13 The Procter and Gamble Company Dentifrice composition comprising binder system comprising hydrophilic clay material
CN101316571A (zh) * 2005-11-29 2008-12-03 宝洁公司 不含磨料的洁齿剂组合物
SG169990A1 (en) * 2005-12-21 2011-04-29 Colgate Palmolive Co Improved oral compositions comprising zinc citrate and/or tocopherol agents
US20100021573A1 (en) 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
CN101367745A (zh) * 2008-10-20 2009-02-18 许昌元化生物科技有限公司 纳米氨基酸络合物制备新工艺
KR101595033B1 (ko) * 2009-06-24 2016-02-17 챨스 엔.에스. 소파카 메탈로프로테아제 치료에 대한 반응성을 증대시키기 위한 아연 보충 방법
BR112012022935B1 (pt) * 2010-03-31 2022-03-22 Colgate-Palmolive Company Composição de higiene oral
US9149057B2 (en) * 2011-03-01 2015-10-06 Zinpro Corporation Enhanced bioavailable iodine molecules
US8741375B2 (en) * 2011-06-07 2014-06-03 Zinpro Corporation Mixed amino acid metal salt complexes
CN104884033B (zh) * 2012-12-19 2018-04-20 高露洁-棕榄公司 锌氨基酸络合物与半胱氨酸
BR112015014445A2 (pt) * 2012-12-19 2017-07-11 Colgate Palmolive Co complexo de zinco-lisina
BR112015014758B1 (pt) * 2012-12-19 2019-04-09 Colgate-Palmolive Company Produtos de cuidado oral compreendendo óxido de zinco e trimetilglicina

Also Published As

Publication number Publication date
RU2015123675A (ru) 2017-01-25
BR112015014566B1 (pt) 2020-03-10
JP6348509B2 (ja) 2018-06-27
TWI507211B (zh) 2015-11-11
IL239124A0 (en) 2015-07-30
WO2014099167A3 (en) 2014-12-04
KR20150097562A (ko) 2015-08-26
WO2014099226A3 (en) 2014-09-25
EP2934450B1 (en) 2017-03-01
HK1216015A1 (zh) 2016-10-07
BR112015014760A2 (pt) 2017-07-11
MX2015007672A (es) 2015-09-07
JP2016504996A (ja) 2016-02-18
CA2892217A1 (en) 2014-06-26
RU2627118C2 (ru) 2017-08-03
CL2015001792A1 (es) 2015-09-04
CN105142599B (zh) 2018-08-07
AU2013364204B2 (en) 2016-03-03
TWI522117B (zh) 2016-02-21
RU2015123704A (ru) 2017-01-25
CN105142599A (zh) 2015-12-09
EP2934451B1 (en) 2017-01-04
MY170532A (en) 2019-08-14
CN104853813B (zh) 2018-07-10
PH12015501336A1 (en) 2015-09-02
MX369505B (es) 2019-11-11
EP2934449B1 (en) 2018-01-10
HK1216020A1 (zh) 2016-10-07
IN2015DN04226A (es) 2015-10-16
EP2934450A2 (en) 2015-10-28
CN104853730A (zh) 2015-08-19
CN104853813A (zh) 2015-08-19
WO2014099165A2 (en) 2014-06-26
PH12015501342A1 (en) 2015-09-07
AU2013364205A1 (en) 2015-06-11
EP2934696B1 (en) 2017-07-26
AU2013363649A1 (en) 2015-06-11
JP6392779B2 (ja) 2018-09-19
BR112015014300B1 (pt) 2020-03-10
WO2014099165A3 (en) 2015-01-29
AU2013363649B2 (en) 2015-11-26
MX2015007673A (es) 2015-09-07
RU2618472C2 (ru) 2017-05-03
MX2015007674A (es) 2015-09-07
EP2934452B1 (en) 2017-09-20
RU2629086C2 (ru) 2017-08-24
WO2014099166A3 (en) 2014-10-16
CA2892359C (en) 2021-03-09
RU2015123694A (ru) 2017-01-26
BR112015014300A2 (pt) 2017-07-11
CA2892360A1 (en) 2014-06-26
CA2892190A1 (en) 2014-06-26
KR20150097491A (ko) 2015-08-26
RU2015123715A (ru) 2017-01-24
EP2934451A2 (en) 2015-10-28
CA2892427C (en) 2021-06-08
TW201436813A (zh) 2014-10-01
WO2014099226A2 (en) 2014-06-26
CN104853729A (zh) 2015-08-19
KR20150097493A (ko) 2015-08-26
CN104853729B (zh) 2018-06-12
WO2014099166A2 (en) 2014-06-26
MX368895B (es) 2019-10-21
KR102030761B1 (ko) 2019-10-10
TW201429497A (zh) 2014-08-01
EP2934696A2 (en) 2015-10-28
KR102161832B1 (ko) 2020-10-06
JP2016504332A (ja) 2016-02-12
CA2892217C (en) 2020-12-01
HK1216016A1 (zh) 2016-10-07
TW201440797A (zh) 2014-11-01
TW201429498A (zh) 2014-08-01
MX368896B (es) 2019-10-21
WO2014099164A3 (en) 2015-01-29
AU2013364204A1 (en) 2015-06-11
PH12015501337A1 (en) 2015-09-02
AU2013364205B2 (en) 2015-10-22
MX2015007780A (es) 2015-09-04
AU2013364202A1 (en) 2015-06-11
IL239003A0 (en) 2015-07-30
EP2934452A2 (en) 2015-10-28
CA2892360C (en) 2021-03-09
BR112015014477A2 (pt) 2017-07-11
BR112015014478A2 (pt) 2017-07-11
TWI510251B (zh) 2015-12-01
EP2934449A2 (en) 2015-10-28
PH12015501344A1 (en) 2015-09-07
CL2015001760A1 (es) 2015-08-21
MX354637B (es) 2018-03-14
RU2015123649A (ru) 2017-01-25
MX362447B (es) 2019-01-18
BR112015014566A2 (pt) 2017-07-11
TWI499433B (zh) 2015-09-11
WO2014099167A2 (en) 2014-06-26
WO2014099164A2 (en) 2014-06-26
KR20150097505A (ko) 2015-08-26
CN104884033A (zh) 2015-09-02
AR094077A1 (es) 2015-07-08
RU2634261C2 (ru) 2017-10-24
IN2015DN04211A (es) 2015-10-16
CN104884033B (zh) 2018-04-20
CN108186382A (zh) 2018-06-22
AU2013364202B2 (en) 2015-08-13
CN104853730B (zh) 2019-05-14
RU2625757C2 (ru) 2017-07-18
CA2892359A1 (en) 2014-06-26
AU2013364203A1 (en) 2015-06-11
CA2892190C (en) 2020-10-27
CA2892427A1 (en) 2014-06-26
MX2015007783A (es) 2015-09-04
AU2013364203B2 (en) 2015-10-15
PH12015501338A1 (en) 2015-09-02
CL2015001694A1 (es) 2015-08-21

Similar Documents

Publication Publication Date Title
CL2015001695A1 (es) Una composicion de dos componentes para entregar zinc a un cuerpo comprendiendo (i) un primer componente de un complejo de halogenuro de zinc y (aminoacido o trialquilglicina) y (ii) un segundo componente de cisteina, en donde el primer y segundo componente se mantienen separados uno del otro hasta que se dispensan y se combinan para aplicarse al cuerpo, util para el cuidado oral y personal.
CL2014002556A1 (es) Compuestos derivados de ácidos indaniloxidihidrobenzofuranilacéticos, agonistas del receptor gpr40; composiicon farmaceutica; y su uso en el tratamiento de enfermedades o afecciones como diabetes, resistencia a la insulina, obesidad, entre otras.
CL2014002873A1 (es) Compuestos derivados de pirimidin-amina o triazin-amina, inhibidores de adn-pk; composicion farmaceutica; y su uso para el tratamiento del cancer.
BR112015003397A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente.
CL2013003372A1 (es) Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes.
EA201500535A1 (ru) Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и насыщения, снижения веса, композиция, фармацевтическая композиция, косметическая композиция и лекарственное средство
CL2015001724A1 (es) Compuestos derivados de péptidos, agonistas de oxitocina; composicion farmaceutica; y su uso para en el tratamiento del autismo, estres, ansiedad, depresion, esquizofrenia,entre otros.
BR112015003332A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
BR112015003398A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
DK3632919T3 (da) Farmaceutiske sammensætninger omfattende imidazothiadiazol- og imidazopyrazinderivater som proteaseaktiverede receptor 4-(par4)- hæmmere til behandling af blodpladeaggregering
CL2014001437A1 (es) Compuestos derivados de aril dihidropiridinona y piperidinona como inhibidores de monoacilglicerol aciltransferasa (mgat2); composicion y combinacion farmaceutica; y uso en el tratamiento y prevencion de diabetes, hiperglucemia, retinopatia, sindrome metabolico, entre otras enfermedades.
EP2889308A4 (en) SUPERFAMIL ALPHA O CONOTOXIN PEPTIDE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
BR112014025041B8 (pt) Composição farmacêutica
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
CL2014001704A1 (es) Derivados de amida ciclica como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa; composicion farmaceutica que los comprende y el uso de los mismos en la prevencion o tratamiento de enfermedades tales como la diabetes.
CL2013000881A1 (es) Combinaciones farmacéuticas que comprenden un componente (a) que corresponden a compuestos derivados de difenilurea omega-carboxiaril-sustituidos, (b) compuestos derivados de n-(2-arilamino)arilsulfonamida y (c) que son uno o más agentes farmaceuticos adicionales; y su uso en el tratamiento del cancer
WO2014153009A3 (en) Thiosaccharide mucolytic agents
EP2842568A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF TYPE I DIABETES AND THE USE THEREOF
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
CL2015000056A1 (es) Compuestos derivados de carbamato/urea, inhibidores del receptor de histamina h3; procedimiento de preparación; compuesto intermediario; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de narcolepsia.
CL2012003322A1 (es) Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer.
CL2014002845A1 (es) Compuestos derivados de pirazol inhibidores de sglt1; metodo para tratar la diabetes; composicion farmaceutica; uso del compuesto para el tratamiento de la diabetes tipo 1 y tipo 2.
BR112013014189A8 (pt) composição farmacêutica, uso de um agente de potencialização e uso de uma composição